相关实验视频

Updated: Sep 10, 2025

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

母胎HLA-DQB1不兼容与基因隔离群体的妊娠诱导高血压疾病有关

Liseanne J Van't Hof¹, Marie-Louise P van der Hoorn², Selena Migdis²

¹Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.

|August 22, 2025

概括

母胎HLA- DQB1不匹配可能导致妊娠高血压疾病. 这项研究发现高血压孕妇的HLA- DQB1不匹配增加,这表明在妊娠期间免疫调节的作用.

科学领域:

生殖免疫学
人类遗传学
妇产科

背景情况:

半异质胎儿热囊体表达特定的HLA特征,对胎盘和母白细胞接触至关重要.
矛盾的是,母亲的免疫调节需要胎儿的抗原识别,涉及到特定的HLA分子.
一种严重的高血压并发症 - - 妊娠前与抗原相似性有关,这表明HLA不匹配可能参与无并发症怀孕的免疫调节.

研究的目的:

在基因隔离的群体中研究HLA兼容性的偏好选择.
确定妊娠期间HLA兼容性和高血压并发症之间的关系.

主要方法:

在基因隔离的荷兰人群中进行了嵌套病例对照研究 (125例无并发症,50例高血压怀孕).
对母体和胎儿的HLA-A, -B, -C, -DRB1, -DQA1, -DQB1和母体KIR进行基因定型.
使用PIRCHE-II算法对观察到的母胎HLA (错误) 匹配与预期值进行比较,并预测不匹配的CD4+T细胞表位.

主要成果:

与预期相比,在没有并发症的怀孕中没有观察到母亲和胎儿HLA (错误) 匹配的显著差异.
患有高血压并发症的孕妇表现出明显更高的HLA- DQB1不匹配,与PIRCHE- II得分相关.
两组之间KIR/ HLA- C频率没有显著差异.

结论:

孕妇与胎儿的HLA-DQB1不匹配似乎在该群体中高血压妊娠并发症的病因中起作用.
虽然解释受样本大小和高血压疾病的分组限制,但HLA-DQB1不匹配是妊娠引起的高血压和子宫前的潜在因素.

关键词:

KIR 接收器遗传现象遗传变异亲生繁殖母胎组织相容性分子流行病学在怀孕期间怀孕引起的高血压妊娠前症

更多相关视频

Isolation of Leukocytes from the Human Maternal-fetal Interface

Isolation of Leukocytes from the Human Maternal-fetal Interface

Published on: May 21, 2015

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

相关概念视频

Rh Blood Group

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...